Literature DB >> 33435884

Serum alanine aminotransferase activity and risk factors for cardiovascular disease in a Caucasian population: the Tromsø study.

Svein Ivar Bekkelund1,2.   

Abstract

BACKGROUND: High and low levels of serum alanine aminotransferase (ALT) are both associated with cardiovascular diseases (CVD) risks especially in elderly, but the mechanisms are less known. This study investigated associations between ALT and CVD risk factors including effects of sex and age in a Caucasian population.
METHODS: Cross-sectional data were analysed sex-stratified in 2555 men (mean age 60.4 years) and 2858 women (mean age 60.0 years) from the population study Tromsø 6. Associations were assessed by variance analysis and multivariable logistic regression of odds to have abnormal ALT. Risk factors included body mass index (BMI), waist-to-hip-ratio, blood pressure, lipids, glucose, glycated haemoglobin and high-sensitive C-reactive protein (CRP).
RESULTS: Abnormal elevated ALT was detected in 113 men (4.4%) and 188 women (6.6%). Most CVD risk factors associated positively with ALT in both sexes except systolic blood pressure and CRP (women only), while ALT was positively associated with age in men when adjusted for CVD risk factors, P < 0.001. BMI predicted ALT in men (OR 0.94; 95% CI 0.88-1.00, P = 0.047) and women (OR 0.90; 95% CI 0.86-0.95, P < 0.001). A linear inversed association between age and ALT in men and a non-linear inversed U-trend in women with maximum level between 60 and 64 years were found.
CONCLUSION: This study confirms a positive relationship between ALT and CVD risk factors, particularly BMI. Age is not a major confounder in the ALT-CVD relationship, but separate sex-analyses is recommended in such studies.

Entities:  

Keywords:  Age; Alanine aminotransferase; BMI; Population study; Sex difference

Year:  2021        PMID: 33435884      PMCID: PMC7805181          DOI: 10.1186/s12872-020-01826-1

Source DB:  PubMed          Journal:  BMC Cardiovasc Disord        ISSN: 1471-2261            Impact factor:   2.298


  33 in total

1.  Alanine aminotransferase and mortality in patients with type 2 diabetes (ZODIAC-38).

Authors:  Petronella E Deetman; Alaa Alkhalaf; Gijs W D Landman; Klaas H Groenier; Jenny E Kootstra-Ros; Gerjan Navis; Henk J G Bilo; Nanne Kleefstra; Stephan J L Bakker
Journal:  Eur J Clin Invest       Date:  2015-07-03       Impact factor: 4.686

2.  Correlation between serum alanine aminotransferase activity and age: an inverted U curve pattern.

Authors:  Eran Elinav; Iddo Z Ben-Dov; Elizabeth Ackerman; Alexander Kiderman; Frida Glikberg; Yami Shapira; Zvi Ackerman
Journal:  Am J Gastroenterol       Date:  2005-10       Impact factor: 10.864

3.  The obesity paradox and weight loss.

Authors:  Jonathan Myers; Kusum Lata; Shilpy Chowdhury; Paul McAuley; Nikhil Jain; Victor Froelicher
Journal:  Am J Med       Date:  2011-07-26       Impact factor: 4.965

4.  Updated definitions of healthy ranges for serum alanine aminotransferase levels.

Authors:  Daniele Prati; Emanuela Taioli; Alberto Zanella; Emanuela Della Torre; Sonia Butelli; Emanuela Del Vecchio; Luciana Vianello; Francesco Zanuso; Fulvio Mozzi; Silvano Milani; Dario Conte; Massimo Colombo; Girolamo Sirchia
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

5.  Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

6.  Sex-influenced association of nonalcoholic fatty liver disease with coronary heart disease.

Authors:  Mary F Feitosa; Alexander P Reiner; Mary K Wojczynski; Mariaelisa Graff; Kari E North; Jeffrey J Carr; Ingrid B Borecki
Journal:  Atherosclerosis       Date:  2013-01-25       Impact factor: 5.162

7.  Cohort profile: the Tromso Study.

Authors:  Bjarne K Jacobsen; Anne Elise Eggen; Ellisiv B Mathiesen; Tom Wilsgaard; Inger Njølstad
Journal:  Int J Epidemiol       Date:  2011-03-21       Impact factor: 7.196

8.  Gender differences in healthy ranges for serum alanine aminotransferase levels in adolescence.

Authors:  Hossein Poustchi; Jacob George; Saeed Esmaili; Farzaneh Esna-Ashari; Gelayol Ardalan; Sadaf Ghajarieh Sepanlou; Seyed Moayed Alavian
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

Review 9.  Complex association between alanine aminotransferase activity and mortality in general population: a systematic review and meta-analysis of prospective studies.

Authors:  Zhengtao Liu; Huaijun Ning; Shuping Que; Linlin Wang; Xue Qin; Tao Peng
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

10.  Sex-Specific Association between Metabolic Abnormalities and Elevated Alanine Aminotransferase Levels in a Military Cohort: The CHIEF Study.

Authors:  Kai-Wen Chen; Fan-Chun Meng; Yu-Lueng Shih; Fang-Ying Su; Yen-Po Lin; Felicia Lin; Jia-Wei Lin; Wei-Kuo Chang; Chung-Jen Lee; Yi-Hwei Li; Chung-Bao Hsieh; Gen-Min Lin
Journal:  Int J Environ Res Public Health       Date:  2018-03-19       Impact factor: 3.390

View more
  3 in total

1.  Analysis of the relationship between serum alanine aminotransferase and body composition in Chinese women.

Authors:  Shuang Li; Yi Wang; Jieyu He; Wu Huang; Eryuan Liao; Youshuo Liu; Junkun Zhan; Yanjiao Wang
Journal:  Aging Med (Milton)       Date:  2022-05-24

2.  Association between serum alanine and aspartate aminotransferase and blood pressure: a cross-sectional study of Chinese freshmen.

Authors:  Lijun Zhu; Zhengmei Fang; Yuelong Jin; Weiwei Chang; Mengyun Huang; Lianping He; Yan Chen; Yingshui Yao
Journal:  BMC Cardiovasc Disord       Date:  2021-10-01       Impact factor: 2.298

3.  The relationships between FLAIS, a novel insulin sensitivity index, and cardiovascular risk factors in a population-based study.

Authors:  Monika Karczewska-Kupczewska; Agnieszka Nikołajuk; Marcin Kondraciuk; Zofia Stachurska; Marlena Dubatówka; Anna Szpakowicz; Marek Strączkowski; Irina Kowalska; Karol Kamiński
Journal:  Cardiovasc Diabetol       Date:  2022-04-19       Impact factor: 8.949

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.